Giving small babies oxygen: 50 Years of uncertainty

Seminars in Neonatology

Volumn 7, Issue 5, 2002, Pages 361-367

  Tin, Win ^a   Wariyar, Unni ^b  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Oxygen therapy; Pulse oximetry; Retinopathy of prematurity

Indexed keywords

BLINDNESS; CHRONIC LUNG DISEASE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; HYPOXEMIA; OXYGEN THERAPY; PREMATURITY; PULSE OXIMETRY; RETINA DISEASE; RETROLENTAL FIBROPLASIA; REVIEW;

EID: 0036816317     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2002.0130     Document Type: Article

References (31)

1. Patz A, Hoeck LE, de la Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. 1. Nursery observations. Am J Ophthalmol 1952; 35: 1248-1253.
2. Kinsey VE, Jacobus JT, Hemphill F. Retrolental fibroplasia: Cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 1956; 56: 481-543.
3. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: A clinical approach. Med J Austr 1951; ii: 48-50.
4. Crosse VM, Evans PJ. Prevention of retrolental fibroplasia. Arch Ophthalmol 1952; 48: 83-87.
5. 2 levels and retrolental fibroplasia. Pediatrics 1977; 60: 655-668.
6. Usher R. Treatment of respiratory distress. In: Winters RW (ed.) Body Fluids in Pediatrics. Boston: Little Brown, 1973; 303-337.
7. Les Chermignonards Désenchantés. Oxygen and retrolental fibroplasia. Pediatrics 1977; 60: 753-754. (See also Pediatrics 1978; 62: 439-440.)
8. Les Chermignonards Désenchantés. Oxygen and retrolental fibroplasia. Pediatrics 1977; 60: 753-754. (See also Pediatrics 1978; 62: 439-440.)
9. Guy LP, Lanman TJ, Dancis J. The possibility of total elimination of retrolental fibroplasia by oxygen restriction. Pediatrics 1956; 17: 247-249.
10. Avery ME, Oppenheimer EH. Recent increase in mortality in hyaline membrane disease. J Pediatr 1960; 57: 553-559.
11. Cross KW. Cost of preventing retrolental fibroplasia? Lancet 1973; ii: 954-956.
12. Bolton DPG, Cross KW. Further observations on the cost of preventing retrolental fibroplasia. Lancet 1974; i: 445-448.
13. Duc G, Sinclair JC. Oxygen administration. In: Sinclair JC, Bracken B (eds) Effective Care of the Newborn Infant. Oxford: Oxford University Press, 1992; 178-199.
14. Flynn JT, Bancalari E, Bawol R, et al. Retinopathy of prematurity. A randomized prospective trial of transcutaneous oxygen monitoring. Ophthalmology 1987; 94: 630-638.
15. Flynn JT, Bancalari E, Snyder ES, et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050-1054. (See also 1078-1080.)
16. Nicolini U, Nicolaidis P, Fisk NM, et al. Limited role of fetal blood sampling in prediction of outcome in intrauterine growth retardation. Lancet 1990; 336: 768-772.
17. Dawes GS. Pulmonary circulation in the foetus and new-born. Br Med Bull 1966; 22: 61-65.
18. Skinner JR, Hunter S, Poets CF, et al. Haemodynamic effects of altering arterial oxygen saturation in preterm infants with respiratory failure. Arch Dis Child 1999; 80: F81-87.
19. Lacamp C, Walker S. Oxygen monitoring: Too low or too high. National survey of oxygen saturation monitoring policies and the audit on the effect of change of policy in a single neonatal intensive unit [Abstract]. Early Hum Dev 2002 (in press).
20. Vijayakumar E, Ward GJ, Bullock CE, et al. Pulse oximetry in infants <1500 gm at birth on supplemental oxygen: A national survey. J Perinatol 1997; 17: 341-345.
21. Tin W, Milligan DWA, Pennefather P, et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child 2001; 84: F106-F110. (See also commentaries 84: F149-150, and correspondence 85: F75-76.)
22. OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant - The judgement of OSIRIS. Lancet 1992; 340: 1363-1369.
23. Northern Neonatal Nursing Initiative Trial Group. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: Outcome at 2 years. Lancet 1996; 348: 229-232.
24. Tin W, Fritz S, Wariyar U, et al. Outcome of very preterm birth: Children reviewed with ease at 2 years differ from those followed up with difficulty. Arch Dis Child 1998; 79: F83-F87.
25. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicentre trial of cryotherapy for retinopathy of prematurity: One-year outcome - Structure and function. Arch Ophthalmol 1990; 108: 1408-1416.
26. The STOP-ROP Multicentre Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomised, controlled trial. Pediatrics 2000; 105: 295-310.
27. Askie L, Henderson-Smark D, Irwig L, et al. The effect of differing oxygen saturation targeting ranges on long term growth and development of extremely preterm, oxygen dependent infants: The BOOST trial [Abstract]. Pediatr Res 2002; 51: 378A.
28. Hay WW, Brockway JM, Eyzaquirre M. Neonatal pulse oximetry: Accuracy and reliability. Pediatrics 1989; 83: 717-722.
29. Brockway J, Hay WW. Prediction of arterial partial pressure of oxygen with pulse oxygen saturation measurements. J Pediatr 1998; 133: 63-66.
30. Thilo EH, Anderson D, Wasserstein ML, el al. Saturation by pulse oximetry: Comparison of the results obtained by instruments of different brands. J Pediatr 1993; 122: 620-626.
31. Moyle JTB. Pulse Oximetry. London: BMJ Books, 1994; 26-39.